4.5 Article

Diphenylpyrazoles as Replication Protein A Inhibitors

期刊

ACS MEDICINAL CHEMISTRY LETTERS
卷 6, 期 2, 页码 140-145

出版社

AMER CHEMICAL SOC
DOI: 10.1021/ml5003629

关键词

Replication protein A; fragment-based discovery; medicinal chemistry

资金

  1. NIH [5DP1OD006933/8DP1CA174419, R01CA174887, R01GM065484, P01CA092584, S10 RR025677-01]
  2. ARRA [5RC2CA148375, F32ES021690, F32CA174315, 5T21CA9582-24]
  3. Deutscher Akademischer Austausch Dienst (DAAD)
  4. National Council for Scientific and Technological Development-CNPq
  5. Federal University of Minas Gerais/Brazil
  6. NSF [DBI-0922862]
  7. U.S. DOE [DE-AC02-06CH11357]
  8. Cancer Research UK [11566] Funding Source: researchfish

向作者/读者索取更多资源

Replication Protein A is the primary eukaryotic ssDNA binding protein that has a central role in initiating the cellular response to DNA damage. RPA recruits multiple proteins to sites of DNA damage via the N-terminal domain of the 70 kDa subunit (RPA70N). Here we describe the optimization of a diphenylpyrazole carboxylic acid series of inhibitors of these RPA protein interactions. We evaluated substituents on the aromatic rings as well as the type and geometry of the linkers used to combine fragments, ultimately leading to submicromolar inhibitors of RPA70N protein protein interactions.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据